Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.

"WashU Medicine introduces new blood test for Alzheimer’s symptom timing" was originally created and published by Medical ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team found that removing an enzyme from neurons in the brain substantially reduces ...

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...

A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against ...

A blood test could reveal at what age a person will see symptoms of Alzheimer’s disease before they happen, according to a ...

I understand that there is treatment for the beginning stages of Alzheimer's disease that can stave off serious decline.